Graham Capital Management L.P. Purchases 66,825 Shares of Oscar Health, Inc. $OSCR

Key Points

• Graham Capital Management L.P. increased its stake in Oscar Health, Inc. by 52.2% in Q1, now owning approximately 0.08% of the company valued at $2.55 million.
• Multiple analysts have downgraded Oscar Health, with Raymond James changing its rating from "outperform" to "market perform" and Wells Fargo reducing its target price from $16.00 to $10.00.
• Oscar Health's stock is currently down 3.4%, trading at $16.66, with a market cap of $4.31 billion and an average target price from analysts set at $12.07.

Graham Capital Management L.P. increased its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 52.2% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 194,902 shares of the company's stock after buying an additional 66,825 shares during the period. Graham Capital Management L.P. owned 0.08% of Oscar Health worth $2,555,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Southeastern Asset Management Inc. TN increased its stake in Oscar Health by 52.2% in the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after acquiring an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in shares of Oscar Health by 37.8% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after buying an additional 477,634 shares during the period. Man Group plc increased its holdings in shares of Oscar Health by 344.8% in the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after buying an additional 1,405,554 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Oscar Health by 23.8% in the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock worth $3,749,000 after buying an additional 54,938 shares during the period. Finally, Toronto Dominion Bank purchased a new position in shares of Oscar Health in the fourth quarter worth about $1,008,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Up 5.6%

Shares of Oscar Health stock traded up $1.03 during midday trading on Friday, hitting $19.41. The company had a trading volume of 16,354,315 shares, compared to its average volume of 16,577,883. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The stock has a market capitalization of $5.02 billion, a P/E ratio of -23.96 and a beta of 1.87. The company has a 50 day moving average of $15.78 and a 200 day moving average of $15.01. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period last year, the business posted $0.20 EPS. The company's revenue was up 29.0% compared to the same quarter last year. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently commented on OSCR shares. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price objective for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Piper Sandler decreased their price objective on Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a report on Thursday, August 14th. UBS Group restated a "sell" rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Finally, Barclays lowered their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, July 23rd. Four equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Strong Sell" and an average target price of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.